<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Influenza Testing Parameter Details</title>
  <style>
    * {
      margin: 0;
      padding: 0;
      box-sizing: border-box;
    }
    body {
      font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Roboto', 'Oxygen',
        'Ubuntu', 'Cantarell', 'Fira Sans', 'Droid Sans', 'Helvetica Neue', sans-serif;
      -webkit-font-smoothing: antialiased;
      -moz-osx-font-smoothing: grayscale;
      background: #f5f7fa;
      color: #1e293b;
      line-height: 1.6;
      padding: 0;
    }
    .container {
      max-width: 900px;
      margin: 0 auto;
      padding: 40px 20px;
    }
    .header {
      background: #1e3a8a;
      color: white;
      padding: 40px 20px;
      text-align: center;
      margin-bottom: 40px;
    }
    .header h1 {
      font-size: 2rem;
      margin-bottom: 10px;
    }
    .header p {
      opacity: 0.9;
      font-size: 1.1rem;
    }
    .back-link {
      display: inline-block;
      margin-bottom: 20px;
      color: #2563eb;
      text-decoration: none;
      font-weight: 500;
    }
    .back-link:hover {
      text-decoration: underline;
    }
    .content-card {
      background: white;
      border-radius: 10px;
      padding: 30px;
      box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
      margin-bottom: 20px;
    }
    .content-card h2 {
      color: #1e293b;
      font-size: 1.5rem;
      margin-bottom: 15px;
      padding-bottom: 10px;
      border-bottom: 2px solid #e2e8f0;
    }
    .content-card h3 {
      color: #475569;
      font-size: 1.2rem;
      margin-top: 20px;
      margin-bottom: 10px;
    }
    .content-card p {
      margin-bottom: 15px;
      color: #475569;
    }
    .content-card ul, .content-card ol {
      margin-left: 20px;
      margin-bottom: 15px;
      color: #475569;
    }
    .content-card li {
      margin-bottom: 8px;
    }
    .highlight-box {
      background: #eff6ff;
      border-left: 4px solid #2563eb;
      padding: 15px;
      margin: 20px 0;
      border-radius: 4px;
    }
    .parameter-table {
      width: 100%;
      border-collapse: collapse;
      margin: 20px 0;
    }
    .parameter-table th,
    .parameter-table td {
      padding: 12px;
      text-align: left;
      border-bottom: 1px solid #e2e8f0;
    }
    .parameter-table th {
      background: #f8fafc;
      font-weight: 600;
      color: #1e293b;
    }
    .parameter-table td {
      color: #475569;
    }
  </style>
</head>
<body>
  <div class="header">
    <h1>Influenza Testing Parameter</h1>
    <p>Detailed Information and Guidelines</p>
  </div>
  <div class="container">
    <a href="/" class="back-link">‚Üê Back to Dashboard</a>
    
    <div class="content-card">
      <h2>Overview</h2>
      <p>
        The Influenza Testing parameter controls the proportion of students tested daily for 
        influenza virus infection. Regular testing for influenza is an important surveillance 
        tool that can help identify outbreaks early, distinguish influenza from other respiratory 
        illnesses, and guide appropriate public health responses.
      </p>
      <p>
        Influenza testing is particularly valuable during flu season and can help prevent 
        widespread transmission in school settings. Early detection enables rapid implementation 
        of control measures and helps protect vulnerable populations.
      </p>
    </div>

    <div class="content-card">
      <h2>Coverage Levels</h2>
      <p>The parameter can be set to different coverage levels:</p>
      <table class="parameter-table">
        <thead>
          <tr>
            <th>Coverage Level</th>
            <th>Description</th>
            <th>Daily Testing Rate</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>None</strong></td>
            <td>No routine influenza testing program</td>
            <td>0%</td>
          </tr>
          <tr>
            <td><strong>Low</strong></td>
            <td>Testing of symptomatic individuals and during suspected outbreaks</td>
            <td>5-10% of students</td>
          </tr>
          <tr>
            <td><strong>Medium</strong></td>
            <td>Regular surveillance testing during flu season</td>
            <td>10-20% of students</td>
          </tr>
          <tr>
            <td><strong>High</strong></td>
            <td>Comprehensive testing program during peak flu season</td>
            <td>20-30% of students</td>
          </tr>
        </tbody>
      </table>
    </div>

    <div class="content-card">
      <h2>Testing Strategies</h2>
      <h3>None (Baseline)</h3>
      <p>
        No routine influenza testing. Testing may occur only for clinical diagnosis of 
        symptomatic individuals or during confirmed outbreaks. This represents the baseline 
        scenario with minimal surveillance.
      </p>

      <h3>Low Coverage</h3>
      <ul>
        <li>Test students presenting with influenza-like illness (fever, cough, sore throat)</li>
        <li>Targeted testing during suspected influenza outbreaks</li>
        <li>Testing of close contacts when cases are identified</li>
        <li>Optional testing for high-risk individuals (chronic conditions, immunocompromised)</li>
      </ul>

      <h3>Medium Coverage</h3>
      <ul>
        <li>Weekly surveillance testing of a sample of students during flu season</li>
        <li>Testing of all symptomatic students within 24-48 hours</li>
        <li>Enhanced testing during peak flu season (typically December-February)</li>
        <li>Rapid influenza diagnostic tests (RIDTs) for on-site screening</li>
        <li>Integration with local public health surveillance systems</li>
      </ul>

      <h3>High Coverage</h3>
      <ul>
        <li>Daily or near-daily testing during peak flu season</li>
        <li>Comprehensive surveillance of asymptomatic and symptomatic students</li>
        <li>Rapid testing for immediate results and isolation decisions</li>
        <li>Subtype identification (e.g., H1N1, H3N2) for surveillance purposes</li>
        <li>Coordinated response with antiviral treatment protocols</li>
        <li>Real-time monitoring of influenza activity in the school</li>
      </ul>
    </div>

    <div class="content-card">
      <h2>Test Types and Characteristics</h2>
      <h3>Rapid Influenza Diagnostic Tests (RIDTs)</h3>
      <ul>
        <li><strong>Advantages:</strong> Fast results (10-15 minutes), can be performed on-site, lower cost</li>
        <li><strong>Limitations:</strong> Lower sensitivity (50-70%), may miss some cases</li>
        <li><strong>Best Use:</strong> Quick screening, early outbreak detection, immediate isolation decisions</li>
      </ul>

      <h3>Molecular Tests (RT-PCR)</h3>
      <ul>
        <li><strong>Advantages:</strong> High sensitivity and specificity, can identify influenza subtypes</li>
        <li><strong>Limitations:</strong> Longer turnaround time (24-48 hours), requires laboratory processing</li>
        <li><strong>Best Use:</strong> Confirmatory testing, surveillance, subtype identification</li>
      </ul>

      <h3>Multiplex Respiratory Panels</h3>
      <ul>
        <li>Can test for multiple respiratory viruses simultaneously (influenza, RSV, COVID-19)</li>
        <li>Useful for differential diagnosis during respiratory illness season</li>
        <li>More expensive but provides comprehensive information</li>
      </ul>
    </div>

    <div class="content-card">
      <h2>Impact on Disease Transmission</h2>
      <p>
        Influenza testing programs reduce transmission through several mechanisms:
      </p>
      <ul>
        <li><strong>Early Detection:</strong> Identifies cases before widespread transmission occurs</li>
        <li><strong>Isolation:</strong> Enables rapid isolation of infected students</li>
        <li><strong>Antiviral Treatment:</strong> Early testing allows for timely antiviral treatment, which can reduce symptoms and transmission</li>
        <li><strong>Outbreak Control:</strong> Detects clusters early and enables targeted interventions</li>
        <li><strong>Surveillance:</strong> Provides data on influenza activity to guide public health responses</li>
        <li><strong>Differential Diagnosis:</strong> Helps distinguish influenza from other respiratory illnesses</li>
      </ul>
      <div class="highlight-box">
        <strong>Seasonal Considerations:</strong> Influenza testing is most valuable during 
        flu season (typically October through May in temperate climates). Testing outside of 
        flu season may have limited utility unless there are specific concerns about unusual 
        influenza activity.
      </div>
    </div>

    <div class="content-card">
      <h2>Seasonal Patterns and Timing</h2>
      <h3>Flu Season Characteristics</h3>
      <ul>
        <li>Peak activity typically occurs between December and February</li>
        <li>Season can start as early as October and extend into May</li>
        <li>Activity varies by year and geographic location</li>
        <li>Multiple strains may circulate simultaneously</li>
      </ul>

      <h3>Testing Schedule Recommendations</h3>
      <ul>
        <li><strong>Off-Season (June-September):</strong> Minimal or no routine testing unless outbreaks occur</li>
        <li><strong>Early Season (October-November):</strong> Low to medium coverage to detect early activity</li>
        <li><strong>Peak Season (December-February):</strong> Medium to high coverage for maximum protection</li>
        <li><strong>Late Season (March-May):</strong> Medium coverage to monitor for late-season activity</li>
      </ul>
    </div>

    <div class="content-card">
      <h2>Implementation Considerations</h2>
      <h3>Logistical Requirements</h3>
      <ul>
        <li>Test kit procurement and supply chain management</li>
        <li>Staff training on test administration and interpretation</li>
        <li>Infrastructure for sample collection and storage</li>
        <li>Coordination with local public health departments</li>
        <li>Data reporting and surveillance systems</li>
      </ul>

      <h3>Cost Considerations</h3>
      <p>
        Testing programs require financial resources, but costs may be lower than COVID-19 
        testing due to:
      </p>
      <ul>
        <li>Seasonal rather than year-round implementation</li>
        <li>Lower-cost rapid tests available</li>
        <li>Established testing infrastructure from COVID-19 programs</li>
        <li>Potential cost-sharing with public health departments</li>
      </ul>

      <h3>Integration with Other Interventions</h3>
      <p>
        Influenza testing works best when combined with:
      </p>
      <ul>
        <li>Annual influenza vaccination programs</li>
        <li>Hand hygiene and respiratory etiquette</li>
        <li>Environmental cleaning and disinfection</li>
        <li>Stay-home-when-sick policies</li>
        <li>Antiviral treatment protocols for high-risk individuals</li>
      </ul>
    </div>

    <div class="content-card">
      <h2>Best Practices</h2>
      <ul>
        <li>Align testing intensity with seasonal influenza activity</li>
        <li>Use rapid tests for immediate screening and PCR for confirmation when needed</li>
        <li>Implement clear protocols for positive test results (isolation, treatment, contact notification)</li>
        <li>Coordinate with local public health departments for surveillance and reporting</li>
        <li>Consider multiplex testing to distinguish influenza from other respiratory viruses</li>
        <li>Provide support for students in isolation (academic continuity, meal services)</li>
        <li>Maintain accurate records for surveillance and outbreak investigation</li>
        <li>Regularly evaluate testing strategies based on local influenza activity and resources</li>
        <li>Promote annual influenza vaccination as the primary prevention strategy</li>
      </ul>
    </div>
  </div>
</body>
</html>
